Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Non-Current Assets (2016 - 2025)

Pro Dex's Non-Current Assets history spans 12 years, with the latest figure at $13.1 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 18.69% year-over-year to $13.1 million; the TTM value through Dec 2025 reached $54.9 million, down 11.98%, while the annual FY2025 figure was $13.9 million, 12.41% down from the prior year.
  • Non-Current Assets for Q4 2025 was $13.1 million at Pro Dex, down from $13.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $20.8 million in Q2 2023 and bottomed at $13.1 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $16.1 million (2024), against an average of $16.6 million.
  • The largest annual shift saw Non-Current Assets soared 81.11% in 2021 before it decreased 28.98% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $17.2 million in 2021, then grew by 18.81% to $20.5 million in 2022, then dropped by 27.63% to $14.8 million in 2023, then rose by 8.41% to $16.1 million in 2024, then dropped by 18.69% to $13.1 million in 2025.
  • Per Business Quant, the three most recent readings for PDEX's Non-Current Assets are $13.1 million (Q4 2025), $13.6 million (Q3 2025), and $13.9 million (Q2 2025).